24
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Formulation and release kinetics of cephalexin monohydrate from biodegradable polymeric microspheres

&
Pages 195-205 | Received 19 Jun 1994, Published online: 27 Sep 2008

References

  • Bodmeier R., Oh K. H., Chen H. The effect of addition of low molecular weight poly(DL-lactide) on drug release from biodegradable poly(DL-lactide) drug delivery system. International Journal of Pharmaceutics 1989; 51: 1–8
  • Brady J. M., Cutright D. E., Miller R. A., Baltistone G. C. Resorption rate, route of elimination, and ultrastructure of implant site of polylactic acid in the abdominal wall of the rat. Journal of Biomedical Materials and Research 1973; 7: 155–166
  • Bunke C. M., Arnoff G. R., Brier M. E., Sloan R. S., Luft F. C. Cephazolin and cephalexin kinetics in continuous ambulatory peritoneal dialysis. Clinical Pharmacology and Therapeutics 1983; 33: 66–72
  • Deasy P. B. Microencapsulation and Related Processes. Marcel Dekker, New York 1984
  • Donbrow M. Drug release kinetics and microencapsulation design. Development of Drugs in Modern Medicine, J. W. Gorrod, G. G. Gibson, M. Mitchard. Horwood, Chichester 1986; 374–385
  • Fleming L. W., Philips G., Stewart W. K., Scott A. C. Oral ciprofloxacin in the treatment of peritonitis in patients on continuous ambulatory peritoneal dialysis. Journal of Antimicrobial Chemotherapy 1990; 25: 441–448
  • Heygyeli A. F. Use of organ cultures to evaluate biodegradation of polymer implant materials. Journal of Biomedical Materials and Research 1973; 7: 205–214
  • Jalil R., Nixon J. R. Microencapsulation using poly(DL-lactic acid) I: Effect of preparative variables on the microcapsule characteristics and release kinetics. Journal of Microencapsulation 1990; 7: 229–244
  • Kulkarni R. K., Moore E. G., Heygyeli A. F., Leonard F. Biodegradable poly(lactic acid) polymers. Journal of Biomedical Materials and Research 1971; 5: 169–181
  • Ludlam H. A., Barton I., White L., McMullin C., King A., Phillips I. Intraperitoneal ciprofloxacin for the treatment of peritonitis in patients receiving continuous ambulatory peritoneal dialysis (CAPD). Journal of Antimicrobial Chemotherapy 1990; 25: 843–851
  • Luzzi L. A. PhD dissertation, University of Rhode Island, Kingston, RI 1966
  • Luzzi L. A. Microencapsulation. Journal of Pharmaceutical Sciences 1970; 59: 1367–1376
  • Raghunathan Y., Becker C. H. Spray-congealed formulations of sulphaethidole (SETD) and waxes for prolonged-release medication. Journal of Pharmaceutical Sciences 1969; 57: 1748–1755
  • Rubin J., Rogers W. A., Taylor H. M., Everett E. D., Prowant B. F., Fruto L. V., Nolph K. D. Peritonitis during continuous ambulatory peritoneal dialysis. Annals of Internal Medicine 1980; 92: 7–13
  • Sparks R. E. Microencapsulation. Kirk-Othmer Encyclopedia of Chemical Technology, 3rd. ed. John Wiley, New York 1981; Vol. 15: 470–493
  • Vidmar V., Smolčiüü-Bubalo A., Jalšenjak I. Poly(lactic acid) microencapsulated oxytetracycline in vitro and in vivo correlation. Journal of Microencapsulation 1984; 1: 131–136
  • Wood D. A. Biodegradable drug delivery systems. International Journal of Pharmaceutics 1980; 7: 1–18

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.